Significance of Dna Mismatch Repair Genes and Microsatellite Instability in Colorectal Carcinoma in Ibadan, Nigeria

BM Duduyemi^1, , EEU Akang², PA Adegboyega³ and JO Thomas³

¹Department of Anatomic Pathology, Ekiti State University, Ado-Ekiti, Nigeria

²Department of Pathology, University College Hospital, Ibadan, Nigeria

³Department of Pathology, Louisiana State University, Health Sciences Center, Shreveport, LA, USA

Cite this paper:
BM Duduyemi, EEU Akang, PA Adegboyega and JO Thomas. Significance of Dna Mismatch Repair Genes and Microsatellite Instability in Colorectal Carcinoma in Ibadan, Nigeria. American Journal of Medical and Biological Research. 2013; 1(4):145-148. doi: 10.12691/ajmbr-1-4-7

Abstract

Background: Though the incidence of colorectal carcinoma (CRC) is relatively uncommon in Nigeria, compared to the developed countries, recent studies indicate an increasing trend. Our patients often present at an earlier age, which has important implications for the pathogenesis in Nigeria. MLH1, MSH2, MSH6, PMS2 are the commonly mutated MMR genes in descending order of frequency, with PMS1 and MLH3 mutations being very rare. This study attempts to determine the significance of microsatellite instability (MSI) in colorectal carcinogenesis using immunohistochemistry (IHC) for detection of defects of DNA mismatch repair gene (MMR) amongst cases diagnosed at University College Hospital (UCH) Ibadan, Nigeria. Methodology: Suitable consecutive CRC cases identified from UCH, Ibadan, Pathology Department, 2006 files were stained with MMR IHC antibody panel (MLH1, MSH2, MSH6, PMS2). Stained sections were reviewed for nuclear reactivity and graded according to staining intensity (weak +, moderate ++, strong +++, very strong ++++). Result: IHC was performed on 26 cases. The age range is 22-74 years with 9 cases <40 years. One case with no reactivity with any of the antibody was considered unsuitable. Two cases with only PMS2 nuclear reactivity but no reaction with other antibodies were considered equivocal. Five cases had no nuclear reactivity with single antibody: MLH1 (2); MSH2 (3); and one case had no nuclear reactivity with MLH1 & MSH2. These six cases included 3 cases aged 22, 27 and 32 years with tumors showing no nuclear reactivity for MSH2 and (MLH1 & MSH2) respectively. Conclusion: Though the number cases tested are small, the identification of the loss of MMR gene protein (MLH1 and MSH2) by IHC, indicating MSI, in a significant number of the 26 cases tested (23%), particularly young individuals, suggests that defects of DNA mismatch repair genes are important factors in colorectal carcinogenesis in Nigerians.

Keywords:
CRC microsatellite instability MMR IHC

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Globocan 2008.
[2]	Duduyemi BM, Oluwasola AO, Akang EEU, Thomas-Ogunniyi JO. A 16-year review of clinico-pathological pattern of colorectal carcinoma at University College Hospital, Ibadan. Nigerian Journal of Gastroenterology and Hepatology Vol.3 Nos. 1&2 June & Dec., 2011.
[3]	Iliyasu Y, Ladipo JK, Akang EEU, Adebamowo CA, Ajao OG, Aghadiuno PU. A twenty-year review of malignant colorectal neoplasms at the University College Hospital Ibadan, Nigeria. Dis Colon Rectum 1996; 39:536-40.
[4]	Akute OO. Colorectal carcinoma in Ibadan, Nigeria: a 20-year survey- 1971 to 1990. Hepatogastroenterology 2000; 47:709-13.
[5]	Irabor D, Adedeji OA. Colorectal cancer in Nigeria: 40 years on. A review. European Journal of Cancer Care 2009; 18:110-5.
[6]	Adebamowo CA, Adeyi O, Pyatt R, Prior TW, Chadwick RB, de la Chapelle A. Case report on hereditary non-polyposis colon cancer (HNPCC) in Nigeria. Afr J Med Med Sci 2000; 29:71-3.
[7]	Rosai J (Ed): Rosai and Ackerman’s Surgical Pathology. 9th edition. Elsevier, St Louis, Missouri, 2004: pp. 799-818.
[8]	Hamilton SR, Aaltonen LA (Eds.): WHO classification of tumors: Pathology and Genetics of Tumors of the Digestive System. IARC Press, Lyon 2000; 103-19.
[9]	Katherine B. Geiersbach, Wade S. Samowitz. Microsatellite Instability and Colorectal Cancer. Archives of Pathology & Laboratory Medicine: October 2011, Vol. 135, No. 10, pp. 1269-1277.
[10]	Jung SB, Lee HI, Oh HK, Shin IH, Jeon CH. Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer. Cancer Res Treat. 2012 Sep; 44(3):179-186.
[11]	Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol. 2001 Oct 15; 19(20):4074-80.
[12]	Kaur G, Masoud A, Raihan N, Radzi M, Khamizar W, Kam LS. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma. Indian J Med Res. 2011 Aug; 134:186-92.
[13]	Abdul Murad NA, Othman Z, Khalid M, Abdul Razak Z, Hussain R, Nadesan S, Sagap I, Mohamed Rose I, Wan Ngah WZ, Jamal R. Missense mutations in MLH1, MSH2, KRAS, and APC genes in colorectal cancer patients in Malaysia. Dig Dis Sci. 2012 Nov; 57(11):2863-72.
[14]	Martínez-Urueña N, Alvarez LM, Pérez-Cabornero L, Sanz MI, Aras EL, Hernández JJ, Pino CM, Sarmiento RG, Domínguez MD. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer. Colorectal Dis. 2013 Feb 1. doi: 10.1111/codi.12112. [Epub ahead of print].
[15]	Tanskanen T, Gylfe AE, Katainen R, Taipale M, Renkonen-Sinisalo L, Mecklin JP, Järvinen H, Tuupanen S, Kilpivaara O, Vahteristo P, Aaltonen LA. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Scand J Gastroenterol. 2013 Apr 2. [Epub ahead of print].